Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
Queen Elizabeth II Health Sciences Centre
🇨🇦
Canada
Country
🇨🇦
Canada
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Fecal Microbiota Therapy for Recurrent Clostridium Difficile Infection
Phase 2
Conditions
Clostridium Difficile Infection
Interventions
Biological: Fecal Microbiota
Drug: vancomycin
Drug: Loperamide
Drug: metronidazole
Subscribe
First Posted Date
2016-02-19
Last Posted Date
2016-09-27
Lead Sponsor
Queen Elizabeth II Health Sciences Centre
Target Recruit Count
50
Registration Number
NCT02686645
Subscribe
Brain Trauma Outcomes in Nova Scotia Study
Not Applicable
Completed
Conditions
Brain Injuries,Traumatic
Outcome Assessment (Health Care)
Craniocerebral Trauma
Emergency Medical Services
Organizational Innovation
Subscribe
First Posted Date
2010-10-21
Last Posted Date
2010-10-21
Lead Sponsor
Queen Elizabeth II Health Sciences Centre
Target Recruit Count
52
Registration Number
NCT01225692
Subscribe
Prevention of Instent Renarrowing With Aggressive Glucose Lowering With Pioglitazone in Diabetic Patients
Phase 4
Completed
Conditions
Coronary Artery Disease
Angina Pectoris
Type 2 Diabetes Mellitus
Percutaneous Coronary Intervention
Interventions
Drug: pioglitazone
Drug: oral hypoglycemic agents
Subscribe
First Posted Date
2009-01-08
Last Posted Date
2009-01-08
Lead Sponsor
Queen Elizabeth II Health Sciences Centre
Target Recruit Count
50
Registration Number
NCT00819325
Locations
🇨🇦
Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada
Subscribe
The Safety and Immunogenicity of Acellular Pertussis Vaccine in Bone Marrow Transplant Recipients
Phase 4
Conditions
Pertussis
Subscribe
First Posted Date
2006-06-12
Last Posted Date
2007-10-23
Lead Sponsor
Queen Elizabeth II Health Sciences Centre
Target Recruit Count
10
Registration Number
NCT00336115
Subscribe
Prev
1
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy